Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle

American Journal of Physiology - Endocrinology and Metabolism - Tập 287 Số 5 - Trang E834-E841 - 2004
Ji Li1, Xiaoyue Hu, Pradeepa Selvakumar, Raymond R. Russell, Samuel W. Cushman, Geoffrey D. Holman, Lawrence H. Young
1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA

Tóm tắt

AMP-activated protein kinase (AMPK) is a serine-threonine kinase that regulates cellular metabolism and has an essential role in activating glucose transport during hypoxia and ischemia. The mechanisms responsible for AMPK stimulation of glucose transport are uncertain, but may involve interaction with other signaling pathways or direct effects on GLUT vesicular trafficking. One potential downstream mediator of AMPK signaling is the nitric oxide pathway. The aim of this study was to examine the extent to which AMPK mediates glucose transport through activation of the nitric oxide (NO)-signaling pathway in isolated heart muscles. Incubation with 1 mM 5-amino-4-imidazole-1-β-carboxamide ribofuranoside (AICAR) activated AMPK ( P < 0.01) and stimulated glucose uptake ( P < 0.05) and translocation of the cardiomyocyte glucose transporter GLUT4 to the cell surface ( P < 0.05). AICAR treatment increased phosphorylation of endothelial NO synthase (eNOS) ∼1.8-fold ( P < 0.05). eNOS, but not neuronal NOS, coimmunoprecipitated with both the α2 and α1 AMPK catalytic subunits in heart muscle. NO donors also increased glucose uptake and GLUT4 translocation ( P < 0.05). Inhibition of NOS with Nω-nitro-l-arginine and Nω-methyl-l-arginine reduced AICAR-stimulated glucose uptake by 21 ± 3% ( P < 0.05) and 25 ± 4% ( P < 0.05), respectively. Inhibition of guanylate cyclase with ODQ and LY-83583 reduced AICAR-stimulated glucose uptake by 31 ± 4% ( P < 0.05) and 22 ± 3% ( P < 0.05), respectively, as well as GLUT4 translocation to the cell surface ( P < 0.05). Taken together, these results indicate that activation of the NO-guanylate cyclase pathway contributes to, but is not the sole mediator of, AMPK stimulation of glucose uptake and GLUT4 translocation in heart muscle.

Từ khóa


Tài liệu tham khảo

10.1006/abbi.2000.1935

Balon TW and Nadler JL. Nitric oxide mediates skeletal glucose transport. Am J Physiol Endocrinol Metab 270: E258–E259, 1996.

10.1152/ajpendo.1999.276.5.E938

10.1161/01.RES.85.7.575

10.1097/00004647-199902000-00005

10.1152/physrev.00017.2002

10.1152/ajpendo.2000.279.5.E1202

10.1016/S0014-5793(98)01705-0

10.1152/ajpendo.00171.2003

10.1161/01.CIR.104.3.342

10.1161/01.RES.0000082524.34487.31

10.2337/diabetes.49.12.1978

10.1074/jbc.M210621200

10.1016/S0014-5793(03)00560-X

10.1016/S0008-6215(01)00025-8

10.2337/diabetes.49.4.527

Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369–1373, 1998.

10.1152/jappl.1999.87.5.1990

10.2337/diabetes.51.1.159

10.1074/jbc.M306205200

10.2337/diab.46.11.1691

10.1042/bst0310162

10.2337/diabetes.51.8.2572

10.1074/jbc.270.29.17513

10.1016/0005-2760(96)00013-6

10.2337/diabetes.48.8.1667

10.1016/S0960-9822(00)00742-9

10.1152/ajpendo.1997.273.6.E1107

10.1074/jbc.M212831200

10.1016/S1097-2765(01)00251-9

10.1023/A:1020762401408

10.1161/01.RES.83.10.969

10.1152/ajpendo.2002.282.1.E197

10.1111/j.1476-5381.1990.tb14151.x

10.1152/ajpendo.1997.273.1.E220

10.1172/JCI19297

10.1152/ajpheart.1999.277.2.H643

10.1042/bj20030048

10.2337/diabetes.49.4.647

10.1016/j.cardiores.2003.09.019

10.2337/diabetes.53.6.1429

10.1152/ajpendo.00101.2001

10.1172/JCI15211

10.1152/ajpendo.1996.270.2.E299

10.1128/MCB.20.18.6704-6711.2000

10.1074/jbc.M303521200

10.1016/S1071-3581(00)70016-X

10.1161/01.CIR.95.2.415

10.1042/bj3220223

Thông tin
Thông tin xuất bản

American Journal of Physiology - Endocrinology and Metabolism

Tập 287 Số 5

E834-E841

Thông tin tác giả